ISIN | LU0289089384 |
---|---|
Valor Number | 3038201 |
Bloomberg Global ID | |
Fund Name | JPMorgan Funds - Europe Equity Plus Fund A(Perf)acc EUR |
Fund Provider |
J.P. Morgan Bank Luxembourg S.A.
6, route de Trèves L-2633, Senningerberg Grand Duchy of Luxembourg |
Fund Provider | J.P. Morgan Bank Luxembourg S.A. |
Representative in Switzerland |
JPMorgan Asset Management (Switzerland) LLC Genève Phone: +41 22 744 11 11 |
Distributor(s) |
JP Morgan Asset Management (Europe) Sàrl Senningerberg Phone: +352 34 10 1 |
Asset Class | Equities |
EFC Category | Equity Advanced Europe |
Distribution Policy | Accumulation |
Home Country | Luxembourg |
Issuing Condition | The fund management company and/or distributor charges an issuing commission (different commissions can be charged for the same fund depending on the sales channel) |
Redemption Condition | The fund management company and/or distributor charges a redemption commission (different commissions can be charged for the same fund depending on the sales channel) |
Investment Strategy *** | To provide long term capital growth through exposure to European companies, by direct investments in securities of such companies and through the use of derivatives. |
Peculiarities | In Liquidation |
Current Price * | 33.21 EUR | 10.10.2025 |
---|---|---|
Previous Price * | 33.32 EUR | 09.10.2025 |
52 Week High * | 33.38 EUR | 08.10.2025 |
52 Week Low * | 26.22 EUR | 09.04.2025 |
NAV * | 33.21 EUR | 10.10.2025 |
Issue Price * | ||
Redemption Price * | ||
Closing Price * | ||
Indicative Minimum Price | ||
Fund Assets *** | 3,534,776,503 | |
Unit/Share Assets *** | 709,959,898 | |
Trading Information SIX |
YTD Performance | +20.85% |
30.12.2024 - 10.10.2025
30.12.2024 10.10.2025 |
---|---|---|
YTD Performance (in CHF) | +19.73% |
30.12.2024 - 10.10.2025
30.12.2024 10.10.2025 |
1 month | +3.49% |
10.09.2025 - 10.10.2025
10.09.2025 10.10.2025 |
3 months | +4.86% |
10.07.2025 - 10.10.2025
10.07.2025 10.10.2025 |
6 months | +21.56% |
10.04.2025 - 10.10.2025
10.04.2025 10.10.2025 |
1 year | +20.85% |
10.10.2024 - 10.10.2025
10.10.2024 10.10.2025 |
2 years | +47.67% |
10.10.2023 - 10.10.2025
10.10.2023 10.10.2025 |
3 years | +72.97% |
10.10.2022 - 10.10.2025
10.10.2022 10.10.2025 |
5 years | +107.17% |
12.10.2020 - 10.10.2025
12.10.2020 10.10.2025 |
Equity Participation Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Share of Total Fund Assets in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Real Estate Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI Date |
JPM EUR lqdty LVNAV X (T0 acc.) | 7.46% | |
---|---|---|
Novartis AG Registered Shares | 2.85% | |
SAP SE | 2.07% | |
Roche Holding AG | 2.00% | |
ASML Holding NV | 2.00% | |
Allianz SE | 1.47% | |
Nestle SA | 1.41% | |
HSBC Holdings PLC | 1.38% | |
Anheuser-Busch InBev SA/NV | 1.28% | |
AstraZeneca PLC | 1.25% | |
Last data update | 31.08.2025 |
TER *** | 1.70% |
---|---|
TER date *** | 31.12.2024 |
Performance Fee *** | 10.00% |
PTR | |
Max. Management Fee *** | 1.50% |
Ongoing Charges *** | 1.73% |
SRRI ***
|
|
SRRI date *** | 30.09.2025 |